Correlation Between Cingulate Warrants and Sangamo Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Sangamo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Sangamo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and Sangamo Therapeutics, you can compare the effects of market volatilities on Cingulate Warrants and Sangamo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Sangamo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Sangamo Therapeutics.
Diversification Opportunities for Cingulate Warrants and Sangamo Therapeutics
-0.81 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Cingulate and Sangamo is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Sangamo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sangamo Therapeutics and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Sangamo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sangamo Therapeutics has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Sangamo Therapeutics go up and down completely randomly.
Pair Corralation between Cingulate Warrants and Sangamo Therapeutics
Assuming the 90 days horizon Cingulate Warrants is expected to generate 476.08 times less return on investment than Sangamo Therapeutics. In addition to that, Cingulate Warrants is 1.66 times more volatile than Sangamo Therapeutics. It trades about 0.0 of its total potential returns per unit of risk. Sangamo Therapeutics is currently generating about 0.18 per unit of volatility. If you would invest 85.00 in Sangamo Therapeutics on September 13, 2024 and sell it today you would earn a total of 109.00 from holding Sangamo Therapeutics or generate 128.24% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 98.41% |
Values | Daily Returns |
Cingulate Warrants vs. Sangamo Therapeutics
Performance |
Timeline |
Cingulate Warrants |
Sangamo Therapeutics |
Cingulate Warrants and Sangamo Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cingulate Warrants and Sangamo Therapeutics
The main advantage of trading using opposite Cingulate Warrants and Sangamo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Sangamo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sangamo Therapeutics will offset losses from the drop in Sangamo Therapeutics' long position.Cingulate Warrants vs. Puma Biotechnology | Cingulate Warrants vs. Iovance Biotherapeutics | Cingulate Warrants vs. Sarepta Therapeutics | Cingulate Warrants vs. Day One Biopharmaceuticals |
Sangamo Therapeutics vs. Editas Medicine | Sangamo Therapeutics vs. Intellia Therapeutics | Sangamo Therapeutics vs. Bluebird bio | Sangamo Therapeutics vs. Alnylam Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |